Roth C, Moreau J L, Korner M, Jankovic D, Thèze J
Unité d'Immunogénétique Cellulaire, Institut Pasteur, Paris, France.
Eur J Immunol. 1988 Apr;18(4):577-84. doi: 10.1002/eji.1830180414.
B cell-activating factor (BCAF) has been characterized and partially purified from the supernatant of the murine tumor T cell line 373. BCAF has an apparent molecular mass of 15 to 20 kDa when analyzed by Superose 12 fast protein liquid chromatography (FPLC) gel filtration and a pI of 4.5 to 5.0 when analyzed by FPLC chromatofocusing. Concentrated supernatant was applied to a nickel chelating column and unadsorbed active material was further purified by two sequential C4 reverse-phase high-performance liquid chromatography steps. This purification procedure allowed a complete separation of interleukin 2 and interleukin 4 activities from BCAF. This partially purified BCAF induces Ia expression, cell size increase and proliferation of small resting B cells. Furthermore, we have shown that the activity of partially purified BCAF is insensitive to treatment by monoclonal antibodies specific for interleukin 4 and interleukin 5.
B细胞激活因子(BCAF)已从鼠肿瘤T细胞系373的上清液中得到鉴定并部分纯化。通过Superose 12快速蛋白质液相色谱(FPLC)凝胶过滤分析时,BCAF的表观分子量为15至20 kDa,通过FPLC色谱聚焦分析时,其pI为4.5至5.0。将浓缩的上清液应用于镍螯合柱,未吸附的活性物质通过两个连续的C4反相高效液相色谱步骤进一步纯化。该纯化程序可将白细胞介素2和白细胞介素4的活性与BCAF完全分离。这种部分纯化的BCAF可诱导Ia表达、细胞大小增加以及小的静止B细胞增殖。此外,我们已经表明,部分纯化的BCAF的活性对白细胞介素4和白细胞介素5特异性单克隆抗体的处理不敏感。